🇺🇸 FDA
Patent

US 8188049

Peptides having activities of epidermal growth factor and its uses

granted A61KA61K38/00A61K8/64

Quick answer

US patent 8188049 (Peptides having activities of epidermal growth factor and its uses) held by CAREGEN CO., LTD. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K8/64, A61P, A61P1/02